Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Myung‐Ju Ahn | Researchclopedia

Back to researchers

Myung‐Ju Ahn

Chungnam National University ORCID

1,293

Works

71,909

Citations

109

h-index

523

i10-index

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Cancer Immunotherapy and Biomarkers

Affiliations

Hebron University2023–2023

Beth Israel Deaconess Medical Center2015–2015

Amgen (United States)2021–2021

University Medical Center Groningen2016–2016

Memorial Sloan Kettering Cancer Center1996–2023

Top Works

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Roy S. Herbst,Paul Baas,et al.

20156,480 citations

Colorectal Cancer Treatments and Studies

Cancer Genomics and Diagnostics

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

Edward B. Garon,Naiyer A. Rizvi,et al.

20156,161 citations

Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer

Alice T. Shaw,Dong‐Wan Kim,et al.

20133,390 citations

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok,Yi‐Long Wu,et al.

20193,277 citations

Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer

Tony Mok,Yi‐Long Wu,et al.

20163,267 citations

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

Pasi A. Jänne,James Chih‐Hsin Yang,et al.

20152,095 citations

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen,Denis Soulières,et al.

20181,659 citations

Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma

Nayoung Kim,Hong Kwan Kim,et al.

20201,281 citations

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

Ken Kato,Byoung Chul Cho,et al.

20191,206 citations